IRMD IRadimed Corporation
$86.74
▲ 0.58%
52
Value
17
P/E46.96
20
P/B11.26
40
P/S12.85
10
EV/EBITDA34.45
0
Growth
52
Revenue Growth14.4%
65
EPS Growth16.4%
44
FCF Growth-2.5%
44
Momentum
64
12-Month Return70.0%
99
3-Month Return-8.3%
47
1-Month Return-10.9%
33
RSI (14)33.20
50
50/200 MABullish
75
Profitability
62
ROE24.5%
56
ROA20.6%
98
Gross Margin76.8%
63
Operating Margin32.4%
66
Net Margin27.4%
68
FCF Yield2.2%
27
Risk
64
Beta0.91
90
60-Day Volatility30.7%
42
QScore Analysis